丽珠集团分红(华大基因公布2022年度分配预案 拟10派10元)

第三方分享代码
admin 9个月前 (08-16) 财经知识 798 0

3月31日华大基因发布2022年度分配预案,拟10派10元(含税),预计派现金额合计为4.14亿元。派现额占净利润比例为51.55%,这是公司上市以来,累计第7次派现。

公司上市以来历次分配方案一览

日期分配方案派现金额合计(亿元)股息率(%)2022.12.3110派10元(含税)4.141.392021.12.3110派3.5元(含税)1.430.292020.12.3110派3.5元(含税)1.450.302019.12.3110派1.010098元(含税)0.400.152018.12.3110派1元(含税)0.400.112018.06.3010派2元(含税)0.800.122017.12.3110派3元(含税)1.200.18

证券时报•数据宝统计显示,公司今日公布了2022年报,共实现营业收入70.46亿元,同比增长4.14%,实现净利润8.03亿元,同比下降45.06%,基本每股收益为1.9566元,加权平均净资产收益率为8.35%。

资金面上看,近5日主力资金净流出9398.05万元。

北向资金动态显示,深股通最新持有806.12万股,近5日持股量增加67.75万股,增长9.17%。

按申万行业统计,华大基因所属的医药生物行业共有98家公司公布了2022年度分配方案,派现金额最多的是云南白药,派现金额为27.12亿元,其次是药明康德、达安基因,派现金额为26.44亿元、24.56亿元。(数据宝)

丽珠集团分红(华大基因公布2022年度分配预案 拟10派10元)

2022年度医药生物行业分红排名

代码简称每10股送转(股)每10股派现(元)派现金额(万元)派现占净利润比例(%)股息率(%)000538云南白药0.0015.2271207.9290.372.34603259药明康德0.008.9266264413.7830.000.96002030达安基因0.0017.5245603.0645.389.48601607上海医药0.006.1225550.3240.153.05000513丽珠集团0.0016148851.3077.964.46600332白云山0.007.32119007.9030.002.40600196复星医药0.004.2112230.5830.080.98000999华润三九0.001098834.6040.362.36603392万泰生物4.001090448.5419.100.64300122智飞生物5.00580000.0010.610.48000423东阿阿胶0.0011.675866.5097.263.16002821凯莱英0.001865643.7619.880.83300363博腾股份0.0011.0660166.9630.001.73600511国药股份0.007.8259002.1330.042.74002007华兰生物0.00354731.0050.851.43002294信立泰0.00554567.9585.671.83300529健帆生物0.006.753523.9660.171.55600535天士力0.003.349300.352.62300347泰格医药0.005.547572.1723.710.56600085同仁堂0.003.243887.0530.780.69300009安科生物0.002.541726.7659.332.43300676华大基因0.001041391.4351.551.39600750江中药业0.006.540920.6868.654.51000661长春高新0.001040466.599.770.55300759康龙化成5.00335736.7426.000.36000739普洛药业0.002.9734728.9135.111.23002022*ST科华0.00630857.8131.784.71600062华润双鹤0.002.8930049.2825.821.26600079人福医药0.001.626122.5210.520.86002020京新药业0.00325830.8739.002.79300482万孚生物0.00522062.9218.431.15603127昭衍新药4.00421425.8219.940.47688301奕瑞科技4.002921080.5332.870.67002262恩华药业0.00220151.7622.371.23600267海正药业0.001.719893.3840.681.27000915华特达因0.00818746.5235.582.02600211西藏药业0.007.4618496.1650.021.83600713南京医药0.001.418344.4130.802.70603368柳药集团0.005.0818326.8426.122.79688016心脉医疗0.002316554.9746.391.22688161威高骨科0.004.116400.0030.140.72600976健民集团0.001015339.8637.641.89603367辰欣药业0.003.3515167.9743.332.60002399海普瑞0.00114672.9620.180.65000597东北制药0.00114343.1640.961.56688139海尔生物0.004.514242.1823.710.63000756新华制药0.00213477.7532.780.81600557康缘药业0.002.212861.1529.601.33301367怡和嘉业0.002012800.0033.660.76600422昆药集团0.001.612130.0431.661.28688236春立医疗0.003.1312005.6939.021.37301207华兰疫苗5.00312000.3023.090.57300206理邦仪器0.002.0711999.0351.501.65600420国药现代0.00111720.8618.671.02603998方盛制药0.002.611429.6639.983.58300294博雅生物0.00210084.9723.330.60300765新诺威8.001.59756.1813.430.94300026红日药业0.000.39012.4614.440.43688278特宝生物0.002.138664.8430.190.66301096百诚医药0.0088653.3344.571.04830946森萱医药0.0028538.3753.181.15300401花园生物0.001.47714.1120.100.88688505复旦张江0.000.77203.0052.200.65600587新华医疗0.001.57003.1213.930.64688366昊海生科0.0046850.8437.960.44300841康华生物0.0056687.4311.180.39301277新天地5.0056668.0050.401.37002349精华制药0.000.86513.4530.690.51688276百克生物0.001.56192.6134.110.25603122合富中国0.001.55970.7972.180.96300453三鑫医疗3.001.55960.6232.281.46300194福安药业0.000.55948.5629.071.20300233金城医药0.001.55788.8721.180.49688356键凯科技0.009.35606.7830.010.47002393力生制药0.0035519.7958.971.29000919金陵药业0.0015111.3648.551.16688293奥浦迈4.0064918.8246.680.50688621阳光诺和4.0064800.0030.780.60300314戴维医疗0.001.54320.0044.271.11688091上海谊众1.0034316.6430.220.28600513联环药业0.001.54307.1930.471.50300485赛升药业0.000.864142.3320.230.62688131皓元医药4.003.84065.3320.990.27600252中恒集团0.000.13468.7343.890.31688314康拓医疗4.005.23017.4539.860.99002365永安药业0.0012946.8321.000.84002644佛慈制药0.000.52553.2924.100.47000534万泽股份0.000.52503.1224.610.35300110华仁药业0.000.212482.6513.730.46002873新天药业0.0012319.7619.980.55832735德源药业2.003.52283.4218.931.76688253英诺特0.001.662258.6114.990.57835892中科美菱0.001.81741.1633.111.17300142沃森生物0.000.11601.352.200.02300239东宝生物0.000.261543.3714.100.35600272开开实业0.000.51215.0030.410.45600488津药药业0.000.11096.3630.970.22603079圣达生物0.000.61027.1332.620.42

注:本文系新闻报道,不构成投资建议,股市有风险,投资需谨慎。

分红送转

送转、高送转、分红、分配预案、分配方案

声明:证券时报力求信息真实、准确,文章提及内容仅供参考,不构成实质性投资建议,据此操作风险自担

下载“证券时报”官方APP,或关注官方,即可随时了解股市动态,洞察政策信息,把握财富机会。

2023-03-31 何奎 2023-03-31 09:55

相关推荐